MannKind Corporation revenue by segment MNKD

Annual Quarterly

MannKind Corporation splits its revenue into 7 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Product Revenue at $61.5 million, 60% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2026	Q3 FY2026 Sep 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024
Revenue	413	102	109	90	112	82	77	78	77
Product Revenue	265 +42.1% share 64.1%	62 +27.5% share 60.4%	72 +60.2% share 65.4%	56 +17.0% share 62.0%	76 +66.1% share 67.7%	48 share 58.8%	45 share 58.4%	48 share 61.0%	46 share 59.4%
Product	—	—	42 +87.0% share 38.4%	34 +78.7% share 37.6%	50 +118.6% share 45.0%	22 share 27.2%	22 share 29.3%	19 share 24.2%	23 share 30.0%
Royalty	136 +12.0% share 32.9%	37 +12.4% share 36.8%	32 +3.7% share 29.6%	33 share 36.3%	34 share 30.0%	33 share 40.6%	31 share 40.8%	—	—
Furoscix	—	—	22 share 20.3%	15 share 17.2%	—	—	—	—	—
V Go	14 -19.4% share 3.3%	3 -14.0% share 3.2%	3 -32.8% share 2.5%	3 -23.1% share 3.5%	4 -9.0% share 3.9%	4 share 4.6%	4 share 5.4%	4 share 5.2%	5 share 6.2%
Services	12 +111.4% share 3.0%	3 +436.1% share 2.8%	5 +773.3% share 5.0%	2 +168.8% share 1.7%	3 -37.1% share 2.3%	1 share 0.7%	1 share 0.8%	1 share 0.7%	4 share 5.4%
Manufacturing Services	—	—	—	2 +700.0% share 2.7%	0 -92.6% share 0.4%	—	—	0 share 0.4%	5 share 7.0%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: MNKD (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Danbury, CT
SEC filer status: Large accelerated filer
SEC CIK: 899460

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.